Dr. Federico Garrido is Professor Emeritus in the Department of Biochemistry, Molecular Biology and Immunology at the University of Granada Medical School. Prof Garrido was born in Granada (Spain) and obtained his MD and PhD degree in 1974 from the University of Granada. He did his postdoctoral fellowship at the laboratory of Prof Hilliard Festenstein at the London Hospital Medical College and at the Deutsches Krebsforschungszentrum in Heidelberg working on the Immunogenetic of the MHC. In 1981 he became Professor and Head of the Department of Immunology at the University Hospital “Virgen de las Nieves” in Granada. He served as an elected president of the Spanish Society of Immunology (1987-1991) and of the European Federation for Immunogenetics (2004-2008). Dr. Garrido dedicated his scientific career to the investigation of the role of the loss of tumour HLA class-I expression in cancer immune escape.

• Chapter 1: The discovery of the Major Histocompatibility Complex (MHC): The H-2 in mice and the HLA in humans.- Chapter 2: The discovery of the biological function of the MHC.- Chapter 3: HLA genes and molecules.- Chapter 4: HLA in transplantation.- Chapter 5: HLA class-I loss and cancer Immune escape.- Chapter 6: HLA and disease association.- Chapter 7: HLA in population genetics.

Dr. Federico Garrido is Professor Emeritus in the Department of Biochemistry, Molecular Biology and Immunology at the University of Granada Medical School. Prof Garrido was born in Granada (Spain) and obtained his MD and PhD degree in 1974 from the University of Granada. He did his postdoctoral fellowship at the laboratory of Prof Hilliard Festenstein at the London Hospital Medical College and at the Deutsches Krebsforschungszentrum in Heidelberg working on the Immunogenetic of the MHC. In 1981 he became Professor and Head of the Department of Immunology at the University Hospital “Virgen de las Nieves” in Granada. He served as an elected president of the Spanish Society of Immunology (1987-1991) and of the European Federation for Immunogenetics (2004-2008). Dr. Garrido dedicated his scientific career to the investigation of the role of the loss of tumour HLA class-I expression in cancer immune escape.

• Chapter 1: The discovery of the Major Histocompatibility Complex (MHC): The H-2 in mice and the HLA in humans.- Chapter 2: The discovery of the biological function of the MHC.- Chapter 3: HLA genes and molecules.- Chapter 4: HLA in transplantation.- Chapter 5: HLA class-I loss and cancer Immune escape.- Chapter 6: HLA and disease association.- Chapter 7: HLA in population genetics.

Dr. Federico Garrido is Professor Emeritus in the Department of Biochemistry, Molecular Biology and Immunology at the University of Granada Medical School. Prof Garrido was born in Granada (Spain) and obtained his MD and PhD degree in 1974 from the University of Granada. He did his postdoctoral fellowship at the laboratory of Prof Hilliard Festenstein at the London Hospital Medical College and at the Deutsches Krebsforschungszentrum in Heidelberg working on the Immunogenetic of the MHC. In 1981 he became Professor and Head of the Department of Immunology at the University Hospital “Virgen de las Nieves” in Granada. He served as an elected president of the Spanish Society of Immunology (1987-1991) and of the European Federation for Immunogenetics (2004-2008). Dr. Garrido dedicated his scientific career to the investigation of the role of the loss of tumour HLA class-I expression in cancer immune escape.

• Chapter 1: The discovery of the Major Histocompatibility Complex (MHC): The H-2 in mice and the HLA in humans.- Chapter 2: The discovery of the biological function of the MHC.- Chapter 3: HLA genes and molecules.- Chapter 4: HLA in transplantation.- Chapter 5: HLA class-I loss and cancer Immune escape.- Chapter 6: HLA and disease association.- Chapter 7: HLA in population genetics.